布罗苏马布用于无法识别的瘤诱导的骨髓损伤
Yi Shan Der1, Santosh Chaubey1, Anna Mclean1,2
1Department of Endocrinology Cairns Hospital Cairns Queensland Australia.
Clinical case reports
|January 22, 2026
概括
当瘤隐藏时,瘤诱导的骨质疏松症 (TIO) 很难治疗. 抗FGF23抗体布罗苏马布有效治疗TIO,应该是澳大利亚的一线选择.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 瘤诱导的骨质疏松症 (TIO) 存在诊断和治疗方面的挑战,通常是由于无法切除或隐藏的原发性瘤.
- 纤维细胞生长因子23 (FGF23) 与TIO的病理生理学有关.
- 目前存在治疗限制,特别是在澳大利亚等某些地区的可访问性和补贴地位方面.
研究的目的:
- 评估布罗苏马布作为瘤诱导骨质疏松症 (TIO) 的一线治疗方法的疗效和作用.
- 突出针对FGF23在管理TIO中的潜力.
- 倡导在TIO的临床实践中考虑布罗苏马布.
主要方法:
- 临床病例审查和治疗经验.
- 服用布罗苏马布,一种针对FGF23.23的单克隆抗体.
- 监测与骨质疏松相关的生物化学和临床参数.
主要成果:
- 布罗苏马布在治疗瘤诱导的骨质疏松症方面表现出有效性.
- 反FGF23疗法解决了TIO的潜在机制.
- 随着布罗苏马布治疗,观察到积极的临床结果.
结论:
- 布罗苏马布是一种可行的和有效的第一线治疗瘤诱导的骨质疏松症.
- 用布罗苏马布准FGF23为TIO提供了一个有前途的治疗策略.
- 应该审查澳大利亚的临床指南和可访问性,以促进对TIO的布罗苏马布的使用.
更多相关视频
10:03Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
10.2K
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
23.4K
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Induced-fit Model
89.0K
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
89.0K
Induced Pluripotent Stem Cells
27.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
